| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $19K | — | — |
| Cost of Revenue | $4K | — | — |
| Gross Profit | $14K | — | — |
| R&D Expense | $411K | — | -11.9% |
| SG&A Expense | $1.6M | — | +46.2% |
| Operating Income | -$2.0M | — | -27.6% |
| Interest Expense | $119K | — | — |
| Net Income | -$2.1M | — | -34.9% |
| EPS (Basic) | -$0.06 | — | -20.0% |
| EPS (Diluted) | -$0.06 | — | -20.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $3K | +0.0% | — |
| Inventory | $148K | -7.3% | — |
| Current Assets | $3.4M | -29.3% | -5.6% |
| Total Assets | $3.9M | -29.0% | -20.4% |
| Current Liabilities | $6.7M | -9.0% | +256.2% |
| Total Liabilities | $6.7M | -9.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.4M | — | -34.7% |
| Financing Cash Flow | $6K | — | — |
| +254.6% |
| Stockholders' Equity | -$2.8M | -51.9% | -190.8% |